Medtronic plc (MDT)
Market Cap | 100.91B |
Revenue (ttm) | 32.36B |
Net Income (ttm) | 3.68B |
Shares Out | 1.28B |
EPS (ttm) | 2.76 |
PE Ratio | 28.51 |
Forward PE | 14.73 |
Dividend | $2.80 (3.56%) |
Ex-Dividend Date | Jun 28, 2024 |
Volume | 3,688,346 |
Open | 78.62 |
Previous Close | 78.46 |
Day's Range | 78.32 - 79.45 |
52-Week Range | 68.84 - 89.26 |
Beta | 0.83 |
Analysts | Hold |
Price Target | 90.82 (+15.4%) |
Earnings Date | Aug 20, 2024 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for MDT stock is "Hold." The 12-month stock price forecast is $90.82, which is an increase of 15.40% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/u/h/press16-2526848.jpg)
Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research
Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory...
![](https://cdn.snapi.dev/images/v1/x/n/gen37-2484319-2515873.jpg)
4 Cheap Stocks to Buy Ahead of Earnings
Cigna, Merck, Toll Brothers, Medtronic could see shares gain after proving their earnings growth remains strong.
![](https://cdn.snapi.dev/images/v1/c/m/press3-2515555.jpg)
Nasal Packing Devices: Global Market Forecasts from 2024 to 2029 Featuring Strategic Analysis of Meril Life, Anthony Products, Medtronic, Entsho, and Innovia Medical Among Others
Dublin, July 09, 2024 (GLOBE NEWSWIRE) -- The "Nasal Packing Devices Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.
![](https://cdn.snapi.dev/images/v1/8/p/press7-2504307.jpg)
Medtronic Digital Transformation Strategy Report 2024: Accelerators, Incubators, and Other Innovation Programs
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Medtronic Plc - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering. The report provides comprehensive...
![](https://cdn.snapi.dev/images/v1/y/8/press11-2497318.jpg)
Medtronic announces departure of Karen Parkhill, Chief Financial Officer
DUBLIN , June 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Karen Parkhill will resign as executive vice president and chief financ...
![](https://cdn.snapi.dev/images/v1/m/z/press13-2491106.jpg)
New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes
With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phen...
![](https://cdn.snapi.dev/images/v1/j/z/press13-2489078.jpg)
Sempra Appoints Jennifer M. Kirk to Board of Directors
SAN DIEGO , June 20, 2024 /PRNewswire/ -- Sempra (NYSE: SRE) (BMV: SRE) today announced the appointment of Jennifer M. Kirk to the company's board of directors effective June 20, 2024.
![](https://cdn.snapi.dev/images/v1/v/n/press9-2480600.jpg)
BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC
TROY, Mich. , June 14, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) as its "Sto...
![](https://cdn.snapi.dev/images/v1/r/l/m02d20220325t2i1595390764w940f-2475649.jpg)
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash ...
![](https://cdn.snapi.dev/images/v1/z/w/conf13-2466859.jpg)
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
DUBLIN , June 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 45th annual Goldman Sachs global healthcare confer...
![](https://cdn.snapi.dev/images/v1/c/c/with-less-than-10-contribution-2465529.jpg)
With Less Than 10% Contribution To Sales How Important Is The Diabetes Segment For Medtronic Stock?
Medtronic's (NYSE: MDT) diabetes segment, which sells insulin pumps, continuous glucose monitoring systems, and consumables has seen its revenue rise at a slower pace of 1.4% annually from $2.4 billio...
![](https://cdn.snapi.dev/images/v1/y/u/press6-2458520.jpg)
Medtronic announces closing of public offering of €3.0 billion of senior notes
DUBLIN , June 3, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the...
![](https://cdn.snapi.dev/images/v1/3/s/press6-2452697.jpg)
Medtronic announces pricing of €3.0 billion of senior notes
DUBLIN , May 29, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €...
![](https://cdn.snapi.dev/images/v1/m/4/142978562-s-2445527.jpg)
Medtronic Q4 earnings: ‘we're optimistic about fiscal 2025'
Medtronic PLC (NYSE: MDT) is in focus on Thursday after reporting market-beating financial results for its fourth quarter. Medtronic issues in-line guidance The stock is flat at writing because $MDT ...
![](https://cdn.snapi.dev/images/v1/q/6/medical21-2445078.jpg)
Medtronic's stock rises after earnings beat expectations and the dividend was raised
Shares of Medtronic PLC MDT, +0.69% rallied 1.3% in premarket trading Thursday, after the medical device and therapies company reported fiscal fourth-quarter profit and revenue that rose above expecta...
![](https://cdn.snapi.dev/images/v1/s/q/p4kbf7nrifl65de5ga3holthr4-2445027.jpg)
Medtronic beats quarterly profit estimates on medical devices strength
Health tech firm Medtronic beat Wall Street estimates for quarterly profit on Thursday, aided by a post-pandemic pickup in surgical volumes at hospitals that boosted demand for its medical devices.
![](https://cdn.snapi.dev/images/v1/f/q/press5-2444998.jpg)
Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase
Broad-based, durable growth across the company, including Cranial & Spinal Technologies, Diabetes, Cardiac Pacing, Surgical, and Structural Heart; gaining momentum as company enters new product cycles...
![](https://cdn.snapi.dev/images/v1/3/n/will-medtronic-stock-see-highe-2441461.jpg)
Will Medtronic Stock See Higher Levels Post Q4 Results After 5% Gains This Year?
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2024 fourth-quarter results on Thursday, May 23 (fiscal ends in April). We expect Medtronic Medtronic stock to trade sideways post-Q4 results an...
![](https://cdn.snapi.dev/images/v1/j/y/press7-2438039.jpg)
Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment
HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of life DUBLIN and BOSTON, May 17, 2024 /P...
![](https://cdn.snapi.dev/images/v1/k/z/press19-2437475.jpg)
Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™
Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm DUBLIN and BOSTON , May 17, 2024 /PRNewswire/...
![](https://cdn.snapi.dev/images/v1/e/x/conf8-2420808.jpg)
Medtronic to announce financial results for its fourth quarter and full fiscal year 2024
DUBLIN , May 9, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal ye...
![](https://cdn.snapi.dev/images/v1/2/i/press8-2420407.jpg)
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
Arecor Therapeutics plc (“Arecor” or the “Company”) ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund Arecor...
![](https://cdn.snapi.dev/images/v1/2/f/press15-2393961.jpg)
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN , April 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare t...
![](https://cdn.snapi.dev/images/v1/c/o/press8-2375405.jpg)
Americans favor quality over quantity in pursuit of longevity
According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues DUBLIN , April 17, 2024...
![](https://cdn.snapi.dev/images/v1/3/j/press3-2368540.jpg)
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care
Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, pre...